{"disease":{"id":"amyloid-beta-protein","name":"amyloid beta protein"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06911944","title":"Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Michael Rafii, MD, PhD","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}